
Keywords: Topical Corticosteroid; Esophageal Eosinophil; Symptom Score; Clinical Trial; AE; adverse event; CSS; Clinical Symptom Score; DSQ; Dysphagia Symptom Questionnaire; EoE; eosinophilic esophagitis; EOT; end of treatment; FDA; Food and Drug Administration; GE